Erythroid differentiation and protoporphyrin IX down-regulate frataxin expression in Friend cells: Characterization of frataxin expression compared to molecules involved in iron metabolism and hemoglobinization

Blood

Volumn 99, Issue 10, 2002, Pages 3813-3822

  Becker, Erika M ^a,b,c   Greer, Judith M ^a,b,c   Ponka, Prem ^a,b,c   Richardson, Des R ^a,b,c  

^a HEART RESEARCH INSTITUTE   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; DIMETHYL SULFOXIDE; FRATAXIN; HEMOGLOBIN; IRON; MESSENGER RNA; PROTOPORPHYRIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CELL DIFFERENTIATION; DOWN REGULATION; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; FRIEDREICH ATAXIA; GENE EXPRESSION; HEME SYNTHESIS; IRON METABOLISM; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION;

EID: 0037093206     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3813     Document Type: Article

References (70)

1. Deciphering the cause of Friedreich ataxia
2. Molecular pathogenesis of Friedreich ataxia
3. Recent advances in the molecular pathogenesis of Friedreich ataxia
4. Aconitase and mitochondrial iron-sulphur protein deficiency in Friedreich ataxia
5. Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion
6. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes
7. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue
8. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia
9. Mitochondrial intermediate peptidase and the yeast frataxin homolog together maintain mitochondrial iron homeostasis in Saccharomyces cerevisiae
10. The yeast frataxin homologue mediates mitochondrial iron efflux
11. Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia
12. Regulation of mitochondrial iron accumulation by Yfh 1p, a putative homolog of frataxin
13. Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in the mitochondrion
14. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin
15. Friedreich's ataxia protein: Phylogenetic evidence for mitochondrial dysfunction
16. The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis
17. Human frataxin maintains mitochondrial iron homeostasis in Saccharomyces cerevisiae
18. Pathology of the heart in Friedreich's ataxia
19. Cardiac iron deposits in Friedreich's ataxia
20. Erythrocyte protoporphyrin levels in patients with Friedreich's and other ataxias
21. Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia
22. Iron in the central nervous system of Friedreich ataxia patients
23. Increased iron in the dentate nucleus of patients with Friedreich's ataxia
24. Frataxin: Its role in iron metabolism and the pathogenesis of Friedreich's ataxia
25. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: A preliminary study
26. Tissue-specific regulation of iron metabolism and heme synthesis: Distinct control mechanisms in erythroid cells
27. Distribution of iron in reticulocytes after inhibition of heme synthesis with succinylacetone: Examination of the intermediates involved in iron metabolism
28. Regulation of iron entry into reticulocytes, I: Feedback inhibitory effect of heme on iron entry into reticulocytes and on heme synthesis
29. Succinylacetone, a potent inhibitor of heme synthesis: Effect on cell growth, heme content and aminolevulinic acid dehydratase activity of murine erythroleukemia cells
30. Study of intracellular iron distribution in rabbit reticulocytes with normal and inhibited heme synthesis
31. Iron utilization in rabbit reticulocytes: A study using succinylacetone as an inhibitor of heme synthesis
32. Iron distribution in Belgrade rat reticulocytes after inhibition of heme synthesis with succinylacetone
33. The effects of inhibition of heme synthesis on the intracellular localisation of iron in rat reticulocytes
34. Iron-dependent self-assembly of recombinant yeast frataxin: Implications for Friedreich ataxia
35. Crystal structure of human frataxin
36. Towards a structural understanding of Friedreich's ataxia: The solution structure of frataxin
37. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: Stimulation of erythroid differentiation by dimethyl sulfoxide
38. Globin messenger-RNA induction during erythroid differentiation of cultured leukemia cells
39. Induction of globin mRNA accumulation by hemin in cultured erythroleukemic cells
40. Sequential induction of heme pathway enzymes during erythroid differentiation of mouse Friend leukemia virus-infected cells
41. Regulation of transferrin receptor mRNA expression: Distinct regulatory features in erythroid cells
42. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective anti-proliferative agents
43. The uptake of iron and transferrin by the human malignant melanoma cell
44. The effect of intracellular iron concentration and nitrogen monoxide on Nramp2 expression and non-transferrin-bound iron uptake
45. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective anti-proliferative agents, IV: The mechanisms involved in inhibiting cell cycle progression
46. Identification and characterization of a second mouse Nramp gene
47. Interferon-γ and lipopolysaccharide regulate the expression of Nramp2 and increase the uptake of iron from low relative molecular mass complexes by macrophages
48. Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene
49. Cloning and characterisation of a mammalian protoncoupled metal-ion transporter
50. Iron uptake from transferrin and transferrin endocytic cycle in Friend erythroleukemia cells
51. Mobilisation of iron from reticulocytes: Identification of pyridoxal isonicotinoyl hydrazone as a new iron chelating agent
52. A study of intracellular iron metabolism using pyridoxal isonicotinoyl hydrazone and other synthetic chelating agents
53. Iron metabolism in K562 erythroleukemia cells
54. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell
55. The effect of various chelating agents on the mobilization of iron from reticulocytes in the presence and absence of pyridoxal isonicotinoyl hydrazone
56. Cell biology of heme
57. A hemin-inducible enhancer lies 4.5 kb upstream of the mouse ferritin H subunit
58. Ferric citrate uptake by cultured rat hepatocytes is inhibited in the presence of transferrin
59. Two mechanisms of iron uptake from transferrin by melanoma cells: The effect of desferrioxamine and ferric ammonium citrate
60. Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free medium
61. Iron uptake and transferrin endocytosis in undifferentiated and differentiated erythroleukemia cells
62. Development of novel aroylhydrazone ligands for iron chelation therapy: The 2-pyridylcarboxaldehyde isonicotinoyl hydrazone (PCIH) analogues
63. Ferrochelatase, glutathione peroxidase and transferrin receptor mRNA synthesis and levels in mouse erythroleukemia cells
64. Transferrin receptors, iron transport and ferritin metabolism in Friend erythroleukemia cells
65. Synthesis of erythrocyte-specific proteins in cultured Friend leukemia cells
66. CCC1 suppresses mitochondrial damage in the yeast model of Friedrech's ataxia by limiting mitochondrial iron accumulation
67. A human mitochondrial ferritin encoded by an intronless gene
68. Inactivation of the Friedreich ataxia mouse gene leads to early embryonic lethality without iron accumulation
69. Frataxin deficiency enhances apoptosis in cells differentiating into neuroectoderm
70. Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload